Search Results
Oct 17, 2025, 17:15 ET FDA approves Novo Nordisk's oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event
your healthcare provider right away if you get symptoms of gallbladder problems, which may include: pain in your upper stomach (abdomen), yellowing of skin or eyes (jaundice), fever, and clay-colored stools food or liquid getting into the lungs during surgery or other procedures that use anesthesia
More news about: Novo Nordisk
Oct 17, 2025, 10:15 ET Connected Worker Market worth $20.18 billion by 2030 - Exclusive Report by MarketsandMarkets™
such as TotalEnergies and Mitsubishi Chemicals. Rugged wristbands and Bluetooth bracelets from Lansitec monitor vital signs, including heart rate and skin temperature, and provide SOS alert functions, which are vital for worker safety in hazardous industrial sites.
More news about: MarketsandMarkets
Oct 17, 2025, 10:00 ET 4 Student Teams' Innovations Win 2025 Collegiate Inventors Competition
infant jaundice in limited-resource settings. BiliRoo is a wearable infant sling that combines filtered sunlight phototherapy and "kangaroo care" (skin-to-skin contact) to enable parental involvement and potential at-home use. GRADUATE:
More news about: Collegiate Inventors Competition
Oct 17, 2025, 10:00 ET Multitude Therapeutics Announces Promising Interim Phase I/II Results from the Ongoing First-in-Human Study Evaluating its CD44v9-directed Antibody-Drug-Conjugate, AMT-116, in Heavily Pretreated EGFR Wild-type Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting
inhibitor-based ADCs, with manageable hematologic toxicities as the most common treatment-related adverse events. Only low-grade and infrequent mucosal and skin toxicities were observed, demonstrating a favorable tolerability profile. "We are excited by the impressive and durable efficacy
More news about: Multitude Therapeutics, Inc.
Oct 17, 2025, 10:00 ET Boehringer's HERNEXEOS® demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC
yellowing of your skin or the white part of your eyes (jaundice) dark or brown (tea colored) urine pain on the
More news about: Boehringer Ingelheim
Oct 17, 2025, 09:03 ET SEATTLE REIGN FC ANNOUNCES MULTI-YEAR UPPER-BACK KIT PARTNERSHIP WITH PAULA'S CHOICE SKINCARE
over 30 years, we've broken down the science of skincare, busted beauty myths and made products with ingredients that research proves can transform skin. Established in 1995 by beauty expert Paula Begoun, Paula's Choice is deeply rooted in our founder's commitment to customer advocacy and education. Our
More news about: Paula's Choice
Oct 17, 2025, 09:00 ET Curology Introduces DayPrimeRx- The first-ever prescription acne treatment and primer
Dermatologist and Medical Director at Curology. "DayPrimeRx eliminates that choice, giving patients one product that immediately blurs the skin, treats skin with prescription actives over time, and holds makeup in place for up to 12 hours thereby maximizing results and minimizing effort."
More news about: Curology
Oct 17, 2025, 08:34 ET Harnessing Molecular Medicine to Accelerate Wound Healing
The Pressure Relief & Prevention Series is specifically designed to address skin injuries caused by medical devices or prolonged immobility. Common scenarios include facial pressure from BiPAP masks, skin damage from drainage tubes or nasogastric tubes, and localized pressure injuries in bedridden
More news about: TAICEND TECHNOLOGY CO,. LTD.
Oct 17, 2025, 08:30 ET MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
announced disastrous Phase 3 trial results for its only product candidate (sonelokimab, or "SLK"), its highly anticipated treatment for patients with skin disease (hidradenitis suppurativa or "HS").
More news about: Hagens Berman Sobol Shapiro LLP
Oct 17, 2025, 08:30 ET Neurocrine Biosciences Presents New KINECT® 4 Post-Hoc Analysis Demonstrating Rapid and Sustained Therapeutic Efficacy of INGREZZA® (valbenazine) 40 mg Capsules
breathing or shortness of breath, swelling of your face, lips, eyelids, tongue, or throat, or other areas of your skin, trouble with swallowing, or rash, including raised, itchy red areas on your skin (hives). Swelling in the throat can be life-threatening and can lead to death. Stop taking INGREZZA or INGREZZA
More news about: Neurocrine Biosciences, Inc.
Oct 17, 2025, 07:31 ET Truekind® to Launch TrueCool Wireless Menopause Bra and TrueCool Mid-Waist Menopause Brief
and all its hormonal fluctuations. I wanted to create a collection that helps other women like myself who are experiencing the hot flashes, irritated skin, and sore, swollen, and tender breasts that are constantly fluctuating in size," she shared. "Truekind is a solutions-based brand that truly cares about
More news about: Truekind
Oct 17, 2025, 07:00 ET CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
ReactionsTreatment with BRINSUPRI is associated with an increase in dermatologic adverse reactions, including rash, dry skin, and hyperkeratosis. Monitor patients for development of new rashes or skin conditions and refer patients to a dermatologist for evaluation of new dermatologic findings.
More news about: Insmed Incorporated
Oct 17, 2025, 06:12 ET Weekly Recap: 13 Consumer Press Releases You Need to See
year-long partnership will extend into community events and opportunities to unlock complimentary access, creating inclusive spaces for the care of both skin and soul.
More news about: PR Newswire
Oct 17, 2025, 05:49 ET Adhesion Barrier Market 2025-30 Outlook Shows 7.5% CAGR as North America Leads Global Growth, Says Mordor Intelligence
Active Wound Care Market : The Active Wound Care Market Report is Segmented by Product (Biomaterials, Skin Substitutes, Growth Factors), End User (Hospitals, Specialty Wound Clinics, Home Healthcare), Application (Chronic Wounds, Acute Wounds), and Geography
More news about: Mordor Intelligence Private Limited
Oct 17, 2025, 01:32 ET FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States
populations.[1] HS, which affects approximately 1%-4% of people in the U.S., is a chronic, inflammatory, recurrent skin condition characterized by painful nodules, abscesses, comedones, fistulas, sinus tracts, and scarring in intertriginous areas. Adolescent HS shares
More news about: Celltrion USA
Oct 16, 2025, 17:36 ET Berger Montague PC Investigating Claims on Behalf of MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors After Class Action Filing
executives made false and misleading statements regarding the Company's only drug candidate, sonelokimab (SLK), in testing as a treatment for certain skin conditions. The complaint alleges that the Company repeatedly promoted SLK's Nanobody structure as providing superior clinical advantages
More news about: Berger Montague
Oct 16, 2025, 15:01 ET MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
announced disastrous Phase 3 trial results for its only product candidate (sonelokimab, or "SLK"), its highly anticipated treatment for patients with skin disease (hidradenitis suppurativa or "HS").
More news about: Hagens Berman Sobol Shapiro LLP
Oct 16, 2025, 14:40 ET Proya Cosmetics Shares Its Vision for the Future of Beauty at Cosmetic 360, Highlighting Scientific Advances and Brand Innovations
features breakthrough Magnetic Skin-Adhering Powder for a seamless, porcelain-like glow and a patented Hyaluronic Acid Encapsulated Powder that delivers targeted moisture to dry areas while oil-absorbing beads control shine, making it perfect for all skin types.
More news about: Proya Cosmetics
Oct 16, 2025, 11:00 ET Wingderm®'s Mesoskin Marks New Milestone in Non-Invasive Delivery with 1.1 Million+ Procedures Worldwide
BEIJING, Oct. 16, 2025 /PRNewswire/ -- Mesoskin, the non-invasive virtual mesotherapy device for skin and scalp care, has been applied in more than 1.1 million procedures worldwide, marking a significant milestone in its journey of innovation and trust.
More news about: Wingderm Electro-optics Ltd.
Oct 16, 2025, 09:03 ET Milk Makeup Extends Its Roots in Music and Culture
voices that shape today's landscape. To create Cardi's luminous look, makeup artist Erika La' Pearl turned to Hydro Grip Gel Skin Tint in shade nine to achieve a radiant, flawless complexion. Packed with triple-powered hyaluronic acid and niacinamide in a weightless gel base, the
More news about: Milk Makeup
Oct 16, 2025, 08:57 ET Dickinson Brands Inc. Celebrates The 5th Annual National Witch Hazel Day on October 21st
scrapes, bug bites, burns, and even newly inked skin. But today's fans are taking it even further—even fresh shaves are getting the witch hazel treatment—the Alcohol-Free Moisturizing Astringent is now a favorite for soothing and comforting newly shaven skin. The brand also has recently introduced their
More news about: Dickinson Brands Inc.
Oct 16, 2025, 08:47 ET Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™
common type of cutaneous lymphoma. In CTCL, T-cells, a type of lymphocyte that plays a role in the immune system, become cancerous and develop into skin lesions, leading to a decrease in the quality of life of patients with this disease due to severe pain and pruritus. Mycosis Fungoides (MF) and Sézary
More news about: Citius Oncology, Inc.
Oct 16, 2025, 08:04 ET NaturVet's 'Lickable' cat supplements make wellness simple
California, NaturVet produces dog, cat and equine products including all-in-one vitamins and targeted solutions for calming, digestion, allergy aids, skin and joint support. Formulated by veterinarians, NaturVet's supplements are made with the highest quality ingredients, which are sourced from trusted
More news about: NaturVet
Oct 16, 2025, 08:00 ET Sass Magazine Celebrates 5th Annual Reader's Choice Awards with Celebration at Tenth Ward Distilling
Co.JKW Beauty Nail Salon/Nail Care La SorellaSpilt Polish Nail & Skin Spa Skincare/Makeup Services Bug and Jane – Self Care SanctuaryJKW
More news about: Sass Magazine
Oct 16, 2025, 07:00 ET First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
for 3D bioprinting and human skin fibroblasts, melanocytes and keratinocytes. The integration of these constructs into a skin-on-a-chip system enables the evaluation of topical and transdermal drug delivery in a non-animal model. In addition, the 3D bioprinting of skin using plant-derived rhCollagen
More news about: CollPlant